Carolyn D. Hurst

5.7k total citations · 1 hit paper
47 papers, 3.5k citations indexed

About

Carolyn D. Hurst is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carolyn D. Hurst has authored 47 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 32 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carolyn D. Hurst's work include Bladder and Urothelial Cancer Treatments (32 papers), Epigenetics and DNA Methylation (18 papers) and Urinary and Genital Oncology Studies (11 papers). Carolyn D. Hurst is often cited by papers focused on Bladder and Urothelial Cancer Treatments (32 papers), Epigenetics and DNA Methylation (18 papers) and Urinary and Genital Oncology Studies (11 papers). Carolyn D. Hurst collaborates with scholars based in United Kingdom, United States and Germany. Carolyn D. Hurst's co-authors include Margaret A. Knowles, Fiona M. Platt, Sarah V. Williams, Claire Taylor, Darren C. Tomlinson, Ian J. Bruce, Adel Jebar, C.F. Johnston, Rebecca L. Ross and Patricia Harnden and has published in prestigious journals such as Nature reviews. Cancer, PLoS ONE and Cancer Cell.

In The Last Decade

Carolyn D. Hurst

47 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

2014 863 citations Margaret A. Knowles, Carolyn D. Hurst profile →

Peers

Countries citing papers authored by Carolyn D. Hurst

Since Specialization

Citations

This map shows the geographic impact of Carolyn D. Hurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn D. Hurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn D. Hurst more than expected).

Fields of papers citing papers by Carolyn D. Hurst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn D. Hurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn D. Hurst. The network helps show where Carolyn D. Hurst may publish in the future.

Co-authorship network of co-authors of Carolyn D. Hurst

This figure shows the co-authorship network connecting the top 25 collaborators of Carolyn D. Hurst. A scholar is included among the top collaborators of Carolyn D. Hurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolyn D. Hurst. Carolyn D. Hurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Affimer-mediated locking of p21-activated kinase 5 in an intermediate activation state results in kinase inhibition 2023 ·Cell Reports ·Heather L. Martin, (unknown), J. William Higgins, Anna A. Tang, Christian Tiede, Thomas J. Taylor, (unknown), (unknown), Iain W. Manfield, Sandra Bell, Ewan E. Morrison, Jacquelyn Bond, Chi H. Trinh, Carolyn D. Hurst, Margaret A. Knowles, (unknown), Darren C. Tomlinson	3
2	The Lund Molecular Taxonomy Applied to Non–Muscle-Invasive Urothelial Carcinoma 2022 ·Journal of Molecular Diagnostics ·Nour‐Al‐Dain Marzouka, Pontus Eriksson, Carina Bernardo, Carolyn D. Hurst, Margaret A. Knowles, Gottfrid Sjödahl, Fredrik Liedberg, Mattias Höglund	16
3	Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro 2022 ·The Journal of Pathology ·(unknown), Carolyn D. Hurst, (unknown), Helen R. McPherson, (unknown), Olivia Alder, Fiona M. Platt, Emma Black, Julie E. Burns, Margaret A. Knowles	4
4	Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight 2021 ·Cell Reports Medicine ·Carolyn D. Hurst, Guo Cheng, Fiona M. Platt, Mauro A. A. Castro, Nour‐Al‐Dain Marzouka, Pontus Eriksson, Emma Black, Olivia Alder, Andrew Lawson, Sia V. Lindskrog, Julie E. Burns, Sunjay Jain, Jo‐An Roulson, (unknown), Jan Köster, A. Gordon Robertson, Iñigo Martincorena, Lars Dyrskjøt, Mattias Höglund, Margaret A. Knowles	31
5	Monitoring of urothelial cancer disease status after treatment by digital droplet PCR liquid biopsy assays 2020 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Graham Hamilton, Carolyn D. Hurst, (unknown), Clare Orange, Margaret A. Knowles, Robert J. Jones, Hing Y. Leung, Tomoko Iwata	13
6	SnapShot: Bladder Cancer 2018 ·Cancer Cell ·Carolyn D. Hurst, Jonathan E. Rosenberg, Margaret A. Knowles	30
7	Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency 2017 ·Cancer Cell ·Carolyn D. Hurst, Olivia Alder, Fiona M. Platt, Alastair Droop, Lucy F. Stead, Julie E. Burns, George J. Burghel, Sunjay Jain, Leszek J. Klimczak, Helen Lindsay, Jo‐An Roulson, Claire Taylor, Helene Thygesen, Angus J.M. Cameron, Anne J. Ridley, Helen R. Mott, Dmitry A. Gordenin, Margaret A. Knowles	198
8	TERT Core Promotor Mutations in Early-Onset Bladder Cancer 2016 ·Journal of Cancer ·Johannes Giedl, Anja Rogler, Andreas B. Wild, Marc‐Oliver Riener, Thomas Filbeck, Maximilian Burger, Petra Rümmele, Carolyn D. Hurst, Margaret A. Knowles, Arndt Hartmann, Ulrike Zinnall, Robert Stoehr	25
9	Polycomb Repressor Complex 1 Member, BMI1 Contributes to Urothelial Tumorigenesis through p16-Independent Mechanisms 2015 ·Translational Oncology ·(unknown), Carolyn D. Hurst, Jo‐An Roulson, Henry M. Wood, Marta Sänchez‐Carbayo, Margaret A. Knowles, Emma Chapman	5
10	Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis 2012 ·Clinical Cancer Research ·Carolyn D. Hurst, Fiona M. Platt, Claire Taylor, Margaret A. Knowles	73
11	Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer 2009 ·Clinical Cancer Research ·Fiona M. Platt, Carolyn D. Hurst, Claire Taylor, Walter M. Gregory, Patricia Harnden, Margaret A. Knowles	202
12	A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene 2009 ·BMC Research Notes ·Carolyn D. Hurst, Tahlita C.M. Zuiverloon, Christian Hafner, Ellen C. Zwarthoff, Margaret A. Knowles	78
13	Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study 2007 ·Clinical Cancer Research ·Lars Dyrskjøt, Karsten Zieger, Francisco X. Real, Núria Malats, Alfredo Carrato, Carolyn D. Hurst, (unknown), Margaret A. Knowles, Per‐Uno Malmström, Manuel de la Torre, Kenneth Wester, Yves Allory, Dimitri Vordos, Aurélie Caillault, François Radvanyi, Anne-Mette K. Hein, Jens Ledet Jensen, Klaus Møller‐Ernst Jensen, Niels Marcussen, Torben F. Ørntoft	154
14	Hospital reduces medication errors using DMAIC and QFD 2007 ·Quality Engineering ·(unknown), Leslie Forrester, Carolyn D. Hurst, (unknown)	22
15	Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer 2007 ·Oncogene ·Darren C. Tomlinson, Carolyn D. Hurst, Margaret A. Knowles	100
16	Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway 2006 ·Oncogene ·Emma Chapman, Carolyn D. Hurst, Eva Pitt, Philip Chambers, (unknown), Margaret A. Knowles	81
17	High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization 2004 ·Oncogene ·Carolyn D. Hurst, Heike Fiegler, Philippa Carr, Sarah Williams, Nigel P. Carter, Margaret A. Knowles	121
18	Application of magnetite and silica–magnetite composites to the isolation of genomic DNA 2000 ·Journal of Chromatography A ·James I. Taylor, Carolyn D. Hurst, Martin J Davies, (unknown), Ian J. Bruce	108
19	The complete mitochondrial DNA sequence of the Atlantic salmon, Salmo salar 1999 ·Gene ·Carolyn D. Hurst, Sylvia E. Bartlett, William S. Davidson, Ian J. Bruce	104
20	Rapid, sensitive, microbial detection by gene amplification using restriction endonuclease target sequences 1997 ·Molecular and Cellular Probes ·Louise Metherell, Carolyn D. Hurst, Ian J. Bruce	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact